Device Trial Radar · NCT04253431
The Characteristics of Different Personal Lancets on Blood Volume and Perceived Pain in Patients With Diabetes Mellitus
Last checked: Nov 20, 2026Latest source record: Feb 5, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
60
Actual
Start
Aug 2013
Primary completion
Aug 2013
Study completion Aug 2013
Sponsor
- Lead sponsor
- HTL-Strefa S.A.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Feb 5, 2020
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Other
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A randomized single-blind study with the use of different lancing devices equipped with personal lancets to determine and to compare the amount of capillary blood volume and perceived pain after a single lancing of the fingertip.
Conditions
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
Interventions
Droplet lancing device (HTL-Strefa S.A.)Device
Microlet 2 lancing device (Bayer)Device
OneTouch Delicia lancing device (LifeScan)Device
ReliOn lancing device (ReliOn)Device
Accu-Chek Softclix lancing device (Roche)Device
BGStar lancing device (Sanofi Aventis)Device
Ultra-Fine 33G lancets (BD)Device
Droplet 33G lancets (HTL-Strefa S.A.)Device
OneTouch Delicia Extra Fine 33G lancets (LifeScan)Device
HaemoFine 33G lancets (HTL-Strefa S.A.)Device
Softclix 28 G lancets (Roche)Device
ReliOn Ultra-Thin Plus 33G lancets (ReliOn)Device
GlucoJect Dual S lancing device (Menarini)Device
Microlet 28G lancets (Bayer)Device
BGStar Ultra-Thin 33G lancets (Sanofi Aventis)Device
Primary outcomes
What the sponsor says the trial is designed to measure.
- Volume (uL) of blood in the capillary tubeTime frame: The blood from the puncture site was collected to the capillaries for 30 seconds, and afterwards amount of the blood was measured using a calibrated ruler
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.